Miorelique (Baclofen)

Baclofen works by activating GABA_B receptors in the spinal cord and brainstem. This activation reduces the release of excitatory neurotransmitters, dampening nerve signals that cause muscle over‑activity, thereby helping to relax stiff or spastic muscles.

The dosage of baclofen is individualized. A qualified prescriber determines the appropriate starting dose, titration schedule, and maintenance dose based on the patient’s condition, response, and renal function. No fixed regimen is provided here.

Safety data for baclofen during pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by the treating physician.

To order Miorelique, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

The most common alternative to baclofen is tizanidine, another centrally acting muscle relaxant. Baclofen primarily targets GABA_B receptors, while tizanidine acts on α2‑adrenergic receptors. Differences in side‑effect profiles, dosing frequency, and renal clearance may influence a clinician’s choice between them.

Miorelique should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

Miorelique is taken orally. The tablet (or other oral form) should be swallowed whole with a glass of water, unless the prescribing information advises otherwise. It is usually taken with or without food as directed by the prescriber.

Serious risks associated with baclofen include seizures, respiratory depression, and severe allergic reactions such as anaphylaxis. Patients should be instructed to seek immediate medical attention if they experience difficulty breathing, convulsions, or signs of a severe allergic response.

Miorelique is contraindicated in patients with known hypersensitivity to baclofen or any of its excipients. Caution is also advised for individuals with severe renal impairment, uncontrolled epilepsy, or those who are pregnant or breastfeeding without a clear medical justification.